SecBot SecBot
SECBOTREPLAY Home › Report › MIRM

MIRM · Christopher Peetz, an officer and director of Mirum Pharmaceuticals,…

Mirum Pharmaceuticals, Inc. · 144 filed Aug 10, 2026 at 16:17 ET

At the news

NEUTRALIMPACT 3/10

144 filed Aug 10, 2026 at 16:17 ET

Christopher Peetz, an officer and director of Mirum Pharmaceuticals, filed a Form 144 notice of intent to sell 20,000 shares of common stock, with an estimated aggregate market value of approximately $1,978,346. This filing signals a planned sale by a key insider, though it is an advance notice of intent and the sale may not be executed. The filing provides no details on the reason for the sale, but the timing and insider status warrant attention.

  • Christopher Peetz (officer and director) filed a Form 144 to sell 20,000 shares of common stock.
  • Estimated aggregate market value of the proposed sale is approximately $1,978,346.
  • The filing date is August 10, 2026, and the sale is intended to be executed on the same date.
  • The shares to be sold are from a stock option exercise on August 10, 2026.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access